by admin | Sep 21, 2021 | Uncategorized
By Craig Lammert, M.D., AIHA Executive Director Currently, the most important treatment goal for autoimmune hepatitis (AIH) is normal liver tests (AST and ALT) and IgG levels. These numbers are used by treating doctors as surrogates for AIH-related liver inflammation....
by admin | Aug 31, 2021 | Uncategorized
Autoimmune Hepatitis Association (AIHA) Founding Member Lisa Devereaux has been a longtime supporter of the AIHA, from making monetary donations to volunteering countless hours connecting with other autoimmune hepatitis (AIH) patients. In this Q&A, she shares more...
by admin | Jun 22, 2021 | Uncategorized
By Erin AndersonAIHA Director of Programs and Advancement If having autoimmune disease were a competition, Lee Gipson (below left) jokes that she would take home the prize over her older sister, Jo McCoy (below right). Gipson has three autoimmune diseases, and McCoy...
by admin | Dec 17, 2020 | Uncategorized
By Craig Lammert, M.D. Steroids are typically used to rapidly control liver inflammation seen in autoimmune hepatitis. Ultimately, a goal of AIH care is to find a chronic immunosuppressive medication regimen that will be well tolerated by patients, control...
by admin | Nov 4, 2020 | Uncategorized
By Craig Lammert, M.D., AIHA Executive Director Welcome to the Autoimmune Hepatitis Association’s new Interface Blog. The name “interface” describes the cellular area in the liver where inflammation associated with AIH is found. It is one place where...
Recent Comments